Solid Biosciences Inc. (SLDB)
Develops gene therapies for rare muscle and heart diseases.
$7.97+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+16.7%
The outlook
Solid Biosciences is trading at $7.97 with strong analyst support—the consensus leans heavily bullish, and the average price target sits roughly 120% above the current price. The stock sits midway in its 52-week range with mixed momentum against its moving averages, reflecting some near-term volatility despite the broader bullish lean.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 12 analysts
Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +120% vs current price
Analyst price target
~12-month · 12 analysts$17.50average target+119.6% vs now
Now $7.97
Low $11.00High $26.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$784.6M
52-wk high
$11.45
52-wk low
$3.79
50-day avg
$8.18
200-day avg
$6.76
Trailing P/E
—